Quick Takeaways
- ARMISTICE CAPITAL, LLC filed SCHEDULE 13G for RANI THERAPEUTICS HOLDINGS-A Common Stock (LMFA).
- Disclosed ownership: 8.8%.
- Date of event: 30 Jun 2025.
ARMISTICE CAPITAL, LLC - 30 Jun 2025 SCHEDULE 13G Report for RANI THERAPEUTICS HOLDINGS-A Common Stock (LMFA)
- Filing Manager
- ARMISTICE CAPITAL, LLC
- Reporting Manager
- Armistice Capital, LLC
- Symbol
- LMFA
- Shares outstanding
- 49,059,772 shares
- Disclosed Ownership
- 4,312,354 shares
- Ownership
- 8.8%
- Form type
- SCHEDULE 13G
- Filing time
- 14 Aug 2025, 21:02:07 UTC
- Date of event
- 30 Jun 2025
- Next filing
- 14 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"ARMISTICE CAPITAL, LLC disclosed 8.8% ownership in RANI THERAPEUTICS HOLDINGS-A Common Stock (LMFA) on 30 Jun 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Aug 2025, 21:02.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Armistice Capital, LLC | 8.8% | 4,312,354 | 0 | 4,312,354 | /s/ Steven Boyd | Steven Boyd - Managing Member | |
| Steven Boyd | 8.8% | 4,312,354 | 0 | 4,312,354 | /s/ Steven Boyd | Steven Boyd |